Clinical Trials
3 trialsNCT07171528 2025-09-12
KOV-02S
National Cancer Center, Korea
Phase 2 Recruiting
NCT04519151 2023-06-08
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer
Sheba Medical Center
Phase 2 Recruiting
NCT02595021 2016-07-26
Total/Subtotal Colectomy in Ovarian Cancer
Shanghai Gynecologic Oncology Group
Phase 2 Unknown